A surgical orthotopic approach for studying the invasive progression of human bladder cancer

The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally inv...

Full description

Saved in:
Bibliographic Details
Published inNature protocols Vol. 14; no. 3; pp. 738 - 755
Main Authors Lorenzatti Hiles, Guadalupe, Cates, Angelica L., El-Sawy, Layla, Day, Kathleen C., Broses, Luke J., Han, Amy L., Briggs, Hannah L., Emamdjomeh, Amir, Chou, Andrew, Abel, Ethan V., Liebert, Monica, Palmbos, Phillip L., Udager, Aaron M., Keller, Evan T., Day, Mark L.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation. A small laparotomy is carried out, and human cancer cells are implanted into the mouse bladder lumen. This reproduces the pathobiological events of human bladder cancer invasion in mice.
AbstractList The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation. A small laparotomy is carried out, and human cancer cells are implanted into the mouse bladder lumen. This reproduces the pathobiological events of human bladder cancer invasion in mice.
The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation.The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation.
The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation. A small laparotomy is carried out, and human cancer cells are implanted into the mouse bladder lumen. This reproduces the pathobiological events of human bladder cancer invasion in mice.
The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the molecular basis is poorly understood, partly because of the lack of uncomplicated and reliable models that recapitulate the biology of locally invasive disease. We developed a surgical grafting technique, characterized by a simple, rapid, reproducible and high-efficiency approach, to recapitulate the pathobiological events of human bladder cancer invasion in mice. This technique consists of a small laparotomy and direct implantation of human cancer cells into the bladder lumen. Unlike other protocols, it does not require debriding of the urothelial lining, injection into the bladder wall, specialized imaging equipment, bladder catheterization or costly surgical equipment. With minimal practice, the procedure can be executed in <10 min. Tumors develop with a high take rate, and most cell lines exhibit local invasion within 4 weeks of implantation.
Audience Academic
Author Briggs, Hannah L.
Palmbos, Phillip L.
Chou, Andrew
El-Sawy, Layla
Udager, Aaron M.
Broses, Luke J.
Keller, Evan T.
Lorenzatti Hiles, Guadalupe
Day, Mark L.
Day, Kathleen C.
Abel, Ethan V.
Liebert, Monica
Han, Amy L.
Cates, Angelica L.
Emamdjomeh, Amir
Author_xml – sequence: 1
  givenname: Guadalupe
  orcidid: 0000-0002-8423-3279
  surname: Lorenzatti Hiles
  fullname: Lorenzatti Hiles, Guadalupe
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, Division of Head and Neck Surgery, Department of Otolaryngology, University of Michigan
– sequence: 2
  givenname: Angelica L.
  surname: Cates
  fullname: Cates, Angelica L.
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, College of Veterinary Medicine, Michigan State University
– sequence: 3
  givenname: Layla
  surname: El-Sawy
  fullname: El-Sawy, Layla
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, European Egyptian Pharmaceutical Industries
– sequence: 4
  givenname: Kathleen C.
  surname: Day
  fullname: Day, Kathleen C.
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center
– sequence: 5
  givenname: Luke J.
  surname: Broses
  fullname: Broses, Luke J.
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center
– sequence: 6
  givenname: Amy L.
  surname: Han
  fullname: Han, Amy L.
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, Department of Pathology, University of Michigan, School of Medicine, Anschutz Medical Campus, University of Colorado Denver
– sequence: 7
  givenname: Hannah L.
  orcidid: 0000-0003-0686-4523
  surname: Briggs
  fullname: Briggs, Hannah L.
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, Division of Head and Neck Surgery, Department of Otolaryngology, University of Michigan
– sequence: 8
  givenname: Amir
  surname: Emamdjomeh
  fullname: Emamdjomeh, Amir
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, College of Pharmacy and Health Sciences, Wayne State University
– sequence: 9
  givenname: Andrew
  surname: Chou
  fullname: Chou, Andrew
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, College of Medicine, University of Cincinnati
– sequence: 10
  givenname: Ethan V.
  surname: Abel
  fullname: Abel, Ethan V.
  organization: University of Michigan Rogel Cancer Center, Department of Molecular and Integrative Physiology, University of Michigan
– sequence: 11
  givenname: Monica
  surname: Liebert
  fullname: Liebert, Monica
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center
– sequence: 12
  givenname: Phillip L.
  surname: Palmbos
  fullname: Palmbos, Phillip L.
  organization: University of Michigan Rogel Cancer Center, Division of Haematology and Oncology, Department of Internal Medicine, University of Michigan
– sequence: 13
  givenname: Aaron M.
  surname: Udager
  fullname: Udager, Aaron M.
  organization: Department of Pathology, University of Michigan
– sequence: 14
  givenname: Evan T.
  orcidid: 0000-0002-7592-7535
  surname: Keller
  fullname: Keller, Evan T.
  email: etkeller@umich.edu
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center, Department of Pathology, University of Michigan
– sequence: 15
  givenname: Mark L.
  orcidid: 0000-0001-7774-2326
  surname: Day
  fullname: Day, Mark L.
  email: mday@umich.edu
  organization: Division of Urologic Oncology, Department of Urology, University of Michigan, University of Michigan Rogel Cancer Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30683938$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rHCEUhoeS0ny0P6A3RehNezGpOqOOl0voRyBQ6MddQdQ5zhpmdatOaP593W7asKEtIoo87_HlnPe0OQoxQNM8J_ic4G54k3vCJG8xGeomtB0eNSdEMNxSIeXRr3vfUjLI4-Y052uMe9Fx8aQ57jAfOtkNJ823FcpLmrzVM4qprGOJW2-R3m5T1HaNXEwol2W89WFCZQ3Ihxud_Q2gCkwJcvYxoOjQetnogMysxxESsjpYSE-bx07PGZ7dnWfN13dvv1x8aK8-vr-8WF21thoqbScMlf0IbBwcN44DNZIyJnqAkXFjGJcYLHXWSWM6Sam2HGRnCMWaWOK6s-bVvm719H2BXNTGZwvzrAPEJStKhOyxlJhV9OUD9DouKVR3lRoEpoRgck9Negblg4slabsrqlZM8Nr2gfFKnf-FqmuEjbd1VM7X9wPB6wNBZQr8KJNeclaXnz8dsi_ujC5mA6PaJr_R6Vb9Hl0FyB6wKeacwP1BCFa7eKh9PFSNh9rFQ-004oHG-qJLHWF17uf_KulemesvYYJ037d_i34CQyzMFw
CitedBy_id crossref_primary_10_1002_ame2_12293
crossref_primary_10_1039_C9LC01006H
crossref_primary_10_3390_cancers12020439
crossref_primary_10_1016_j_prp_2023_154724
crossref_primary_10_1042_BSR20193484
crossref_primary_10_2139_ssrn_4103916
crossref_primary_10_1038_s41585_024_00885_9
crossref_primary_10_18632_aging_203818
crossref_primary_10_3389_fphar_2022_1050774
crossref_primary_10_1016_j_hoc_2021_02_007
crossref_primary_10_1111_jcmm_18225
crossref_primary_10_1080_21655979_2021_2008738
crossref_primary_10_1016_j_ab_2022_114805
crossref_primary_10_1109_ACCESS_2021_3098510
crossref_primary_10_1158_0008_5472_CAN_22_2485
crossref_primary_10_1038_s41596_019_0194_y
crossref_primary_10_1158_0008_5472_CAN_22_2233
crossref_primary_10_1016_j_celrep_2023_113067
crossref_primary_10_1111_php_14048
crossref_primary_10_1002_advs_202302377
crossref_primary_10_4103_azmj_azmj_30_22
Cites_doi 10.1111/bju.12601
10.7554/eLife.33947
10.1371/journal.pone.0059536
10.1016/j.eururo.2005.12.031
10.1158/1535-7163.MCT-12-1150
10.1242/dmm.008888
10.1038/nrc3858
10.4161/cbt.5.4.2509
10.1038/sj.cgt.7700261
10.1200/JCO.2012.46.5740
10.1186/s12885-017-3778-3
10.1158/0008-5472.CAN-16-1656
10.1016/S0022-5347(17)45139-1
10.1098/rsob.170006
10.1111/j.1464-410X.2009.08577.x
10.1038/onc.2017.149
10.3322/caac.21442
10.1016/S0022-5347(01)66923-4
10.1038/s41419-018-0325-3
10.3322/caac.21262
10.1158/1078-0432.CCR-15-2360
10.2165/00003495-200969090-00003
10.1016/S0022-5347(17)35536-2
10.1111/j.1464-410X.2009.09166.x
10.1016/S0022-5347(05)00323-X
10.1126/science.1203486
10.1007/978-1-4939-7234-0_15
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature America, Inc. 2019
COPYRIGHT 2019 Nature Publishing Group
2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature America, Inc. 2019
– notice: COPYRIGHT 2019 Nature Publishing Group
– notice: 2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QG
7T5
7T7
7TM
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PATMY
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PYCSY
RC3
7X8
DOI 10.1038/s41596-018-0112-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
ProQuest Medical Library
Animal Behavior Abstracts
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

ProQuest Central Student
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1750-2799
EndPage 755
ExternalDocumentID A576415856
30683938
10_1038_s41596_018_0112_8
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA154252
– fundername: NCI NIH HHS
  grantid: K08 CA201335
– fundername: NCI NIH HHS
  grantid: P30 CA046592
– fundername: NCATS NIH HHS
  grantid: UL1 TR002240
GroupedDBID ---
0R~
123
29M
39C
3TQ
3V.
4.4
53G
5BI
5M7
70F
7X7
7XC
88E
8FE
8FH
8FI
8FJ
AAEEF
AARCD
AAWYQ
AAYZH
AAZLF
ABAWZ
ABJNI
ABLJU
ABUWG
ACGFO
ACGFS
ACMJI
ACPRK
ADBBV
ADFRT
AENEX
AEUYN
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AHBCP
AHMBA
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
ARMCB
ASPBG
ATCPS
ATWCN
AVWKF
AXYYD
AZFZN
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
DB5
DU5
EBS
EE.
EJD
EMOBN
F5P
FEDTE
FSGXE
FYUFA
FZEXT
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IGS
IHR
INH
INR
ISR
ITC
LGEZI
LK8
LOTEE
M1P
M7P
NADUK
NNMJJ
NXXTH
O9-
ODYON
P2P
PATMY
PQQKQ
PROAC
PSQYO
PYCSY
RNT
RNTTT
SHXYY
SIXXV
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TSG
UKHRP
AAYXX
ACMFV
AFANA
ATHPR
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NFIDA
NPM
PJZUB
PPXIY
PQGLB
PMFND
7QG
7T5
7T7
7TM
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
ID FETCH-LOGICAL-c473t-37b294de5d8f6bf6e2b925574eed56bb5690ec2fcf9bb3922ac6e93b120a1c1f3
IEDL.DBID 7X7
ISSN 1754-2189
1750-2799
IngestDate Thu Jul 10 18:19:15 EDT 2025
Fri Jul 25 09:10:52 EDT 2025
Tue Jun 17 21:08:04 EDT 2025
Tue Jun 10 20:23:07 EDT 2025
Fri Jun 27 04:51:16 EDT 2025
Mon Jul 21 05:36:03 EDT 2025
Thu Apr 24 23:02:30 EDT 2025
Tue Jul 01 00:19:38 EDT 2025
Fri Feb 21 02:37:37 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c473t-37b294de5d8f6bf6e2b925574eed56bb5690ec2fcf9bb3922ac6e93b120a1c1f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0686-4523
0000-0002-8423-3279
0000-0001-7774-2326
0000-0002-7592-7535
PMID 30683938
PQID 2187021101
PQPubID 536306
PageCount 18
ParticipantIDs proquest_miscellaneous_2179409905
proquest_journals_2187021101
gale_infotracmisc_A576415856
gale_infotracacademiconefile_A576415856
gale_incontextgauss_ISR_A576415856
pubmed_primary_30683938
crossref_primary_10_1038_s41596_018_0112_8
crossref_citationtrail_10_1038_s41596_018_0112_8
springer_journals_10_1038_s41596_018_0112_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-03-01
PublicationDateYYYYMMDD 2019-03-01
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle Recipes for Researchers
PublicationTitle Nature protocols
PublicationTitleAbbrev Nat Protoc
PublicationTitleAlternate Nat Protoc
PublicationYear 2019
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Torre (CR2) 2015; 65
Kobayashi, Owczarek, McKiernan, Abate-Shen (CR24) 2015; 15
Siegel, Miller, Jemal (CR1) 2018; 68
Calì, Molon, Viola (CR22) 2017; 7
Chong (CR15) 2006; 5
Schreiber, Old, Smyth (CR23) 2011; 331
Grossman, Wedemeyer, Ren, Wilson, Cox (CR25) 1986; 136
Iyer (CR8) 2013; 31
CR10
Dinney (CR12) 1995; 154
Han (CR11) 2017; 36
Smith (CR6) 2014; 114
Hayashi (CR20) 2016; 22
Gust (CR19) 2013; 12
Brunocilla, Pernetti, Martorana (CR5) 2011; 31
Sabichi (CR27) 2006; 175
Abel (CR28) 2018; 7
Yang (CR17) 2012; 9
Bolenz (CR4) 2010; 106
Huebner (CR14) 2017; 17
Agarwal, Hussain (CR3) 2009; 69
Hu (CR21) 2018; 9
Watanabe (CR16) 2000; 7
Ahmad, Sansom, Leung (CR18) 2012; 5
Jäger (CR13) 2013; 8
Sylvester (CR7) 2006; 49
Chan, Patel, Heston, Larchian (CR9) 2009; 104
Shinohara, Liebert, Wedemeyer, Chang, Grossman (CR26) 1993; 150
Day (CR29) 2017; 77
C Bolenz (112_CR4) 2010; 106
AL Han (112_CR11) 2017; 36
112_CR10
CP Dinney (112_CR12) 1995; 154
RD Schreiber (112_CR23) 2011; 331
RL Siegel (112_CR1) 2018; 68
W Jäger (112_CR13) 2013; 8
AB Smith (112_CR6) 2014; 114
I Ahmad (112_CR18) 2012; 5
G Iyer (112_CR8) 2013; 31
L Chong (112_CR15) 2006; 5
C Hu (112_CR21) 2018; 9
T Hayashi (112_CR20) 2016; 22
RJ Sylvester (112_CR7) 2006; 49
B Calì (112_CR22) 2017; 7
E Brunocilla (112_CR5) 2011; 31
N Agarwal (112_CR3) 2009; 69
KC Day (112_CR29) 2017; 77
T Watanabe (112_CR16) 2000; 7
HB Grossman (112_CR25) 1986; 136
D Huebner (112_CR14) 2017; 17
E Chan (112_CR9) 2009; 104
XH Yang (112_CR17) 2012; 9
KM Gust (112_CR19) 2013; 12
N Shinohara (112_CR26) 1993; 150
EV Abel (112_CR28) 2018; 7
LA Torre (112_CR2) 2015; 65
T Kobayashi (112_CR24) 2015; 15
A Sabichi (112_CR27) 2006; 175
References_xml – volume: 114
  start-page: 719
  year: 2014
  end-page: 726
  ident: CR6
  article-title: Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
  publication-title: BJU Int.
  doi: 10.1111/bju.12601
– volume: 7
  start-page: e33947
  year: 2018
  ident: CR28
  article-title: HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties
  publication-title: Elife
  doi: 10.7554/eLife.33947
– volume: 8
  start-page: e59536
  year: 2013
  ident: CR13
  article-title: Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0059536
– volume: 49
  start-page: 466
  year: 2006
  end-page: 477
  ident: CR7
  article-title: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2005.12.031
– volume: 12
  start-page: 1245
  year: 2013
  end-page: 1254
  ident: CR19
  article-title: Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-12-1150
– volume: 5
  start-page: 323
  year: 2012
  end-page: 332
  ident: CR18
  article-title: Exploring molecular genetics of bladder cancer: lessons learned from mouse models
  publication-title: Dis. Model. Mech.
  doi: 10.1242/dmm.008888
– volume: 15
  start-page: 42
  year: 2015
  end-page: 54
  ident: CR24
  article-title: Modelling bladder cancer in mice: opportunities and challenges
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3858
– ident: CR10
– volume: 5
  start-page: 394
  year: 2006
  end-page: 398
  ident: CR15
  article-title: Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87)
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.5.4.2509
– volume: 7
  start-page: 1575
  year: 2000
  end-page: 1580
  ident: CR16
  article-title: An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies
  publication-title: Cancer Gene Ther.
  doi: 10.1038/sj.cgt.7700261
– volume: 31
  start-page: 3133
  year: 2013
  end-page: 3140
  ident: CR8
  article-title: Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2012.46.5740
– volume: 17
  year: 2017
  ident: CR14
  article-title: An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3778-3
– volume: 77
  start-page: 74
  year: 2017
  end-page: 85
  ident: CR29
  article-title: HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-16-1656
– volume: 136
  start-page: 953
  year: 1986
  end-page: 959
  ident: CR25
  article-title: Improved growth of human urothelial carcinoma cell cultures
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)45139-1
– volume: 31
  start-page: 3503
  year: 2011
  end-page: 3506
  ident: CR5
  article-title: The prognostic role of lymphovascular invasion in urothelial-cell carcinoma of upper and lower urinary tract
  publication-title: Anticancer Res.
– volume: 7
  start-page: 170006
  year: 2017
  ident: CR22
  article-title: Tuning cancer fate: the unremitting role of host immunity
  publication-title: Open Biol.
  doi: 10.1098/rsob.170006
– volume: 104
  start-page: 1286
  year: 2009
  end-page: 1291
  ident: CR9
  article-title: Mouse orthotopic models for bladder cancer research
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2009.08577.x
– volume: 36
  start-page: 5243
  year: 2017
  end-page: 5251
  ident: CR11
  article-title: Fibulin-3 promotes muscle-invasive bladder cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2017.149
– volume: 9
  start-page: 261
  year: 2012
  end-page: 265
  ident: CR17
  article-title: A new method of establishing orthotopic bladder transplantable tumor in mice
  publication-title: Cancer Biol. Med.
– volume: 68
  start-page: 7
  year: 2018
  end-page: 30
  ident: CR1
  article-title: Cancer statistics, 2018
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21442
– volume: 154
  start-page: 1532
  year: 1995
  end-page: 1538
  ident: CR12
  article-title: Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(01)66923-4
– volume: 9
  year: 2018
  ident: CR21
  article-title: Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-0325-3
– volume: 65
  start-page: 87
  year: 2015
  end-page: 108
  ident: CR2
  article-title: Global cancer statistics, 2012
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21262
– volume: 22
  start-page: 2981
  year: 2016
  end-page: 2992
  ident: CR20
  article-title: Not all NOTCH is created equal: the oncogenic role of NOTCH2 in bladder cancer and its implications for targeted therapy
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-2360
– volume: 69
  start-page: 1173
  year: 2009
  end-page: 1187
  ident: CR3
  article-title: Management of bladder cancer: current and emerging strategies
  publication-title: Drugs
  doi: 10.2165/00003495-200969090-00003
– volume: 150
  start-page: 505
  year: 1993
  end-page: 509
  ident: CR26
  article-title: Evaluation of multiple drug resistance in human bladder cancer cell lines
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)35536-2
– volume: 106
  start-page: 493
  year: 2010
  end-page: 499
  ident: CR4
  article-title: Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2009.09166.x
– volume: 175
  start-page: 1133
  year: 2006
  end-page: 1137
  ident: CR27
  article-title: Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)00323-X
– volume: 331
  start-page: 1565
  year: 2011
  end-page: 1570
  ident: CR23
  article-title: Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion
  publication-title: Science
  doi: 10.1126/science.1203486
– volume: 5
  start-page: 394
  year: 2006
  ident: 112_CR15
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.5.4.2509
– volume: 15
  start-page: 42
  year: 2015
  ident: 112_CR24
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3858
– volume: 65
  start-page: 87
  year: 2015
  ident: 112_CR2
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21262
– volume: 175
  start-page: 1133
  year: 2006
  ident: 112_CR27
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)00323-X
– volume: 7
  start-page: 170006
  year: 2017
  ident: 112_CR22
  publication-title: Open Biol.
  doi: 10.1098/rsob.170006
– volume: 154
  start-page: 1532
  year: 1995
  ident: 112_CR12
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(01)66923-4
– volume: 69
  start-page: 1173
  year: 2009
  ident: 112_CR3
  publication-title: Drugs
  doi: 10.2165/00003495-200969090-00003
– volume: 136
  start-page: 953
  year: 1986
  ident: 112_CR25
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)45139-1
– ident: 112_CR10
  doi: 10.1007/978-1-4939-7234-0_15
– volume: 331
  start-page: 1565
  year: 2011
  ident: 112_CR23
  publication-title: Science
  doi: 10.1126/science.1203486
– volume: 104
  start-page: 1286
  year: 2009
  ident: 112_CR9
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2009.08577.x
– volume: 31
  start-page: 3133
  year: 2013
  ident: 112_CR8
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2012.46.5740
– volume: 5
  start-page: 323
  year: 2012
  ident: 112_CR18
  publication-title: Dis. Model. Mech.
  doi: 10.1242/dmm.008888
– volume: 9
  year: 2018
  ident: 112_CR21
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-0325-3
– volume: 7
  start-page: e33947
  year: 2018
  ident: 112_CR28
  publication-title: Elife
  doi: 10.7554/eLife.33947
– volume: 22
  start-page: 2981
  year: 2016
  ident: 112_CR20
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-2360
– volume: 7
  start-page: 1575
  year: 2000
  ident: 112_CR16
  publication-title: Cancer Gene Ther.
  doi: 10.1038/sj.cgt.7700261
– volume: 8
  start-page: e59536
  year: 2013
  ident: 112_CR13
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0059536
– volume: 31
  start-page: 3503
  year: 2011
  ident: 112_CR5
  publication-title: Anticancer Res.
– volume: 77
  start-page: 74
  year: 2017
  ident: 112_CR29
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-16-1656
– volume: 68
  start-page: 7
  year: 2018
  ident: 112_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21442
– volume: 114
  start-page: 719
  year: 2014
  ident: 112_CR6
  publication-title: BJU Int.
  doi: 10.1111/bju.12601
– volume: 36
  start-page: 5243
  year: 2017
  ident: 112_CR11
  publication-title: Oncogene
  doi: 10.1038/onc.2017.149
– volume: 17
  year: 2017
  ident: 112_CR14
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3778-3
– volume: 9
  start-page: 261
  year: 2012
  ident: 112_CR17
  publication-title: Cancer Biol. Med.
– volume: 49
  start-page: 466
  year: 2006
  ident: 112_CR7
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2005.12.031
– volume: 12
  start-page: 1245
  year: 2013
  ident: 112_CR19
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-12-1150
– volume: 150
  start-page: 505
  year: 1993
  ident: 112_CR26
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)35536-2
– volume: 106
  start-page: 493
  year: 2010
  ident: 112_CR4
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2009.09166.x
SSID ssj0047367
Score 2.3959723
Snippet The invasion of bladder cancer into the sub-urothelial muscle and vasculature are key determinants leading to lethal metastatic progression. However, the...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 738
SubjectTerms 631/1647/767/70
631/67/589/1336
Analytical Chemistry
Animal models
Animals
Biological Techniques
Biomedical and Life Sciences
Bladder
Bladder cancer
Cancer
Catheterization
Computational Biology/Bioinformatics
Development and progression
Diagnosis
Disease Models, Animal
Disease Progression
Humans
Implantation
Invasiveness
Laparotomy
Life Sciences
Metastases
Methods
Mice, Inbred NOD
Mice, SCID
Microarrays
Muscles
Neoplasm Invasiveness
Organic Chemistry
Protocol
Surgical equipment
Tumors
Urinary Bladder Neoplasms - pathology
Urinary Bladder Neoplasms - surgery
Urothelial cancer
Xenograft Model Antitumor Assays - methods
Title A surgical orthotopic approach for studying the invasive progression of human bladder cancer
URI https://link.springer.com/article/10.1038/s41596-018-0112-8
https://www.ncbi.nlm.nih.gov/pubmed/30683938
https://www.proquest.com/docview/2187021101
https://www.proquest.com/docview/2179409905
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdby2AvZd9z2xVtDAYbprb1YftpJKOhGyyMboU8DISkSKNQ7DROCv3vdyfL6VJYn_zgk-zTx33ofroj5L1gwjnJdepMhadVvEo19zz1rs4LzypZOryN_H0qT8_5t5mYxQO3LsIqB5kYBPW8tXhGfgyqqMzQW8k_L65SrBqF0dVYQuMh2cXUZQjpKmcbh4uXLFSQBQ3JU2hfD1FNVh13oLgQfpsjlCsHobCll-5K53_U0514aVBDkydkL9qPdNRP-FPywDXPyKO-ouTNc_J7RLv1MkgzihGZdtUuLiwdModTMFFpyCgLnVOw_ehFc60RwU4DUKtP0kFbT0PtPmouUTAtqcW1sXxBzicnv76cprGAQmqB9xUID1PUfO7EvPLSeOkKU4MLUXJQjEIaI8A1drbw1tfGgKFUaCtdzUxeZDq3uWcvyU7TNu41odpJsNzA29LO8sxwYzUXML-syKUoTZaQbBg-ZWN2cSxycalClJtVqh9xBSOucMRVlZCPmyaLPrXGfcTvcE4UpqxoEBPzR6-7Tn39eaZG4DIBeSVkQj5EIt_Cx62OVwyABcxytUV5uEUJe8puvx6mXsU93anbFZiQt5vX2BJxao1r10gD8g1jjSIhr_ols-ENnDOwRhmw8mlYQ7ed_5fx_ft_5YA8BhOu7lFxh2RntVy7N2AmrcxR2AtHZHc0GY-n8ByfTH-c_QXZVw7a
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgheEN8UBhgEQmKKlsR2Ph4QKrCpZVuFxibtAcnYro0mTUlpWtD-Kf5G7vLR0Unsbc-5OPH5fPc73_kO4JXk0rlE6MCZjE6rRBZo4UXgXR7FnmdJ6ug28v44GR6Jz8fyeA3-dHdhKK2y04m1op6Uls7It9AUpSF5K9H76c-AukZRdLVrodGIxa47-40uW_Vu9AnX93Uc72wffhwGbVeBwIqUz3FHmTgXEycnmU-MT1xscsTVqUBrIRNjJPqLzsbe-twYRA-xtonLuYniUEc28hzHvQbrgqMr04P1D9vjLwed7scP1D1r0SaLAP847-KoPNuq0FRSwm9EyWMRqqEVS3jRHvxjEC9EaGvDt3MbbrWIlQ0aEbsDa664C9ebHpZn9-DbgFWLWa0_GcWAynk5PbGsq1XOEBSzuoYtDs4QbbKT4pemnHlWp4Y1ZUFY6VndLZCZU1KFM2ZJGmf34ehKmPsAekVZuEfAtEsQK6J_p50VoRHGaiFRongcJTI1YR_Cjn3KtvXMqa3Gqarj6jxTDccVclwRx1XWh7fLV6ZNMY_LiF_SmigqklFQFs4PvagqNfp6oAbopCF5JpM-vGmJfIkft7q91IBToLpaK5QbK5S4i-3q427pVatFKnUu8314sXxMb1JmXOHKBdGgRqXopuzDw0ZklnNDdxDxL8epbHYydD74fyf--PJfeQ43hof7e2pvNN59AjcRQOZNTt4G9OazhXuKIG1unrU7g8H3q96MfwGiT0tZ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1da9RAcKgVpS_it9GqqyiCEi7JfiR5EDmsR89qEbVwD4U1u7dbCiU5L3dK_5q_zpl8XL2CfevzTja7s_O5MzsD8EJy6ZwSRehMRrdVIgsL4UXoXR4nnmcqdfQa-fO-2j0QHydysgF_-rcwlFbZy8RGUE8rS3fkA1RFaUTeSjzwXVrEl53Ru9nPkDpIUaS1b6fRksieO_2N7lv9dryDZ_0ySUYfvr_fDbsOA6EVKV8gd5kkF1Mnp5lXxiuXmBxt7FSg5pDKGIm-o7OJtz43Bi2JpLDK5dzESVTENvYc570CV1MuY-KxdLJy9nD6pnstamcR4trzPqLKs0GNSpNSf2NKI4tRIK3pxPOa4R_VeC5W26jA0U240dmubNgS2y3YcOVtuNZ2szy9A4dDVi_njSRlFA2qFtXs2LK-ajlD85g11WxxcoZ2JzsufxWUPc-aJLG2QAirPGv6BjJzQkJxzizR5fwuHFwKau_BZlmV7gGwwim0GtHTK5wVkRHGFkIibfEkVjI1UQBRjz5tu8rm1GDjRDcRdp7pFuMaMa4J4zoL4PXqk1lb1uMi4Od0JprKZZREeEfFsq71-NtXPUR3DcEzqQJ41QH5Cn9ui-55A26BKmytQW6vQSI_2_Xh_uh1J09qfUb9ATxbDdOXlCNXumpJMChbKc4pA7jfksxqb-gYoiXMcStveho6m_y_G3948VKewnVkQf1pvL_3CLbQkszb5Lxt2FzMl-4xWmsL86RhCwY_LpsP_wKPC04p
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+surgical+orthotopic+approach+for+studying+the+invasive+progression+of+human+bladder+cancer&rft.jtitle=Nature+protocols&rft.au=Lorenzatti+Hiles+Guadalupe&rft.au=Cates%2C+Angelica+L&rft.au=El-Sawy%2C+Layla&rft.au=Day%2C+Kathleen+C&rft.date=2019-03-01&rft.pub=Nature+Publishing+Group&rft.issn=1754-2189&rft.eissn=1750-2799&rft.volume=14&rft.issue=3&rft.spage=738&rft.epage=755&rft_id=info:doi/10.1038%2Fs41596-018-0112-8&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1754-2189&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1754-2189&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1754-2189&client=summon